Company intelligence
Acandis GmbH
Engineering Stroke Solutions
About Acandis GmbH
ENGINEERING Stroke Solutions Acandis, founded in 2006, is a privately held German medical device company focused on the prevention and treatment of stroke. We have a passion for technology and our engineers are enthusiastic about creating solutions for unmet clinical needs to improve patient’s lives. We strive towards a comprehensive device portfolio and continuous development of products and services to improve stroke care for neurointerventionalists around the globe. The safety of our products has been demonstrated on the bench top and now the efficacy of those products is being proven in clinical trials. As a company we believe that our employees and our partners in development, production and distribution are the foundation for continuous innovation and commercial success in a fast growing market and so we cultivate a culture of freedom and responsibility. We are growing fast and while we value the energy of youth, we also place high importance on experience. We develop and manufacture for worldwide distribution in Pforzheim, which is located at the edge of the Black Forest recreation area, conveniently situated between Karlsruhe and Stuttgart. www.acandis.com
Verified activity
Signals from Acandis GmbH
6 published signals
Presence & Recognition
Acandis GmbH hosted its first international workshop in Brazil led by Dr. Elias Tanus at IEC for three days of clinical exchange and hands-on learning.
Reported by Acandis GmbH
Presence & Recognition
Acandis GmbH attended the ESMINT2026 conference and presented the SILANCE Stent product.
Reported by Acandis GmbH
Legal & Regulatory
Acandis GmbH's SILANCE Stent has entered clinical evaluation in the SONIC study for Idiopathic Intracranial Hypertension associated with symptomatic cerebral venous sinus stenosis.
Reported by Acandis GmbH
Presence & Recognition
Acandis GmbH hosted an evening in Marseille featuring a RESOLVE Study evaluating the new SIREX Stent and a SONIC Study investigating the new SILANCE Stent.
Reported by Acandis GmbH
Research & Knowledge
Acandis GmbH reached the halfway point towards its recruitment target in the RESOLVE Study, treating 39 patients for pulsatile tinnitus.
Reported by Acandis GmbH
Presence & Recognition
Acandis GmbH announced that Dr. Hannes Nordmeyer will present at the New Tech Symposium on the evolving field of venous sinus stenting, highlighting the SILANCE® Stent* for Idiopathic Intracranial Hypertension and pulsatile tinnitus.
Reported by Acandis GmbH